AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30809801 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle intervention including physical activity, nutritional counseling, vascular risk management, cognitive training, and social activity.
Number of subjects: 1260
Study 30809801 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle intervention
Number of subjects: 1260
Study 30809801 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1260
Study 30031005 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Power Holmium laser enucleation of the prostate (LP-HoLEP)
Number of subjects: 121
Study 30031005 — intervention group
Group type: COMPARATOR
Intervention: High-Power Holmium laser enucleation of the prostate (HP-HoLEP)
Number of subjects: 121
Study 27179847 — intervention group
Group type: EXPERIMENTAL
Intervention: Helmet NIV
Number of subjects: 83
Study 27179847 — intervention group
Group type: COMPARATOR
Intervention: Face mask NIV
Number of subjects: 83
Study 24452632 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal gels containing antiretroviral drugs
Number of subjects: 16
Study 24452632 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal gels
Number of subjects: 16
Study 24452632 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbicide acceptability improvements
Number of subjects: 16
Study 24452632 — intervention group
Group type: EXPERIMENTAL
Intervention: Education for users
Number of subjects: 16
Study 23213953 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous therapeutic ultrasound on the neck (0.5 w/cm2, five times a day)
Number of subjects: 100
Study 23213953 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed isometric exercises specific for the cervical spine and transcutaneous electrical stimulation (TENS)
Number of subjects: 100
Study 23213953 — intervention group
Group type: COMPARATOR
Intervention: Control group (ultrasound machine switched off)
Number of subjects: 100
Study 19657359 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 27
Study 19657359 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study 18443399 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar cautery tonsillectomy
Number of subjects: 201
Study 18443399 — intervention group
Group type: COMPARATOR
Intervention: Classical dissection tonsillectomy
Number of subjects: 201
Study 18443399 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 201
Study 19423958 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep inspiration-gated radiation therapy (n=33)
Number of subjects: 80
Study 19423958 — intervention group
Group type: COMPARATOR
Intervention: Standard radiation therapy (n=47)
Number of subjects: 80
Study 15222838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohabited before engagement
Number of subjects: 136
Study 15222838 — intervention group
Group type: COMPARATOR
Intervention: Cohabited after engagement or at marriage
Number of subjects: 136
Study 11560567 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine 15 g
Number of subjects: 14
Study 11560567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 9677633 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline sulfate nebulization
Number of subjects: 28
Study 9677633 — intervention group
Group type: COMPARATOR
Intervention: Control group (half diluted physiologic serum)
Number of subjects: 28
Study 8156520 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with cyclophosphamide (4.5-6.0 g/m2), etoposide (750-1500 mg/m2), and cisplatin (120-180 mg/m2) with autologous marrow support
Number of subjects: 76
Study 8156520 — intervention group
Group type: COMPARATOR
Intervention: High-dose chemotherapy with cyclophosphamide, etoposide, and cisplatin without autologous marrow support
Number of subjects: 76
Study 3280114 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer factor (TF)
Number of subjects: 168
Study 3280114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 30674084 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat
Number of subjects: 176
Study 30674084 — intervention group
Group type: COMPARATOR
Intervention: Gelfoam
Number of subjects: 176
Study 28238606 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA-VAT
Number of subjects: 1117
Study 28238606 — intervention group
Group type: COMPARATOR
Intervention: CT-VAT
Number of subjects: 1117
Study 26890997 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-Exercise group (GN-Ex, n=10)
Number of subjects: 21
Study 26890997 — intervention group
Group type: COMPARATOR
Intervention: Nutrition group (GN, n=11)
Number of subjects: 21
Study 24914630 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mL mepivacaine 2% (group concentration I)
Number of subjects: 90
Study 24914630 — intervention group
Group type: COMPARATOR
Intervention: 24 mL of mepivacaine 1% (group volume II)
Number of subjects: 90
Study 22732644 — intervention group
Group type: EXPERIMENTAL
Intervention: MOXY fiber (180 watts)
Number of subjects: 50
Study 22732644 — intervention group
Group type: COMPARATOR
Intervention: 4090 fiber (120 watts)
Number of subjects: 50
Study 22732644 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 19050607 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline instillation (8 mL of saline before tracheal suctioning)
Number of subjects: 262
Study 19050607 — intervention group
Group type: COMPARATOR
Intervention: Control (no saline instillation before tracheal suctioning)
Number of subjects: 262
Study 19050607 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline instillation
Number of subjects: 262
Study 19050607 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 262
Study 17323667 — intervention group
Group type: EXPERIMENTAL
Intervention: AMBU Laryngeal Mask
Number of subjects: 0
Study 17323667 — intervention group
Group type: COMPARATOR
Intervention: LMA Classic
Number of subjects: 0
Study 16136635 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethics consultations
Number of subjects: 0
Study 16136635 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ethics consultations)
Number of subjects: 0
Study 11860536 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic assisted vaginal hysterectomy (LAVH) and bilateral salpingo-oophrectomy (BSO) plus minus laparoscopic pelvic lymphadenectomy (LPLA)
Number of subjects: 61
Study 11860536 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (TAH) and BSO plus minus pelvic lymphadenectomy (PLA)
Number of subjects: 61
Study 10451477 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil and fish oil supplement (40 g/d of olive oil and 16 g of fish oil for 3 months)
Number of subjects: 25
Study 10451477 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil and fish oil supplement
Number of subjects: 25
Study 10451477 — intervention group
Group type: COMPARATOR
Intervention: Refined olive oil (Control group)
Number of subjects: 25
Study 7561177 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 400 mg until bone marrow recovery or initiation of intravenous amphotericin B infusions
Number of subjects: 96
Study 7561177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 2193036 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonography
Number of subjects: 68
Study 2193036 — intervention group
Group type: COMPARATOR
Intervention: Clinical examination
Number of subjects: 68
Study 2193036 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration under sonographic control
Number of subjects: 68
Study 646496 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy/antrectomy (TV + A)
Number of subjects: 90
Study 646496 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric selective vagotomy/pyloroplasty (GSV + P)
Number of subjects: 90
Study 646496 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy (PGV)
Number of subjects: 90
Study 29514368 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of 100 mg hydrocortisone (given 2 hours before and 8 hours after surgery)
Number of subjects: 103
Study 29514368 — intervention group
Group type: EXPERIMENTAL
Intervention: Four doses of 100 mg hydrocortisone (8 hours apart)
Number of subjects: 103
Study 29514368 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 103
Study 27838661 — intervention group
Group type: EXPERIMENTAL
Intervention: ASPIRA web-based, multimedia program
Number of subjects: 1369
Study 27838661 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1369
Study 25548844 — intervention group
Group type: EXPERIMENTAL
Intervention: incobotulinumtoxinA
Number of subjects: 14
Study 25548844 — intervention group
Group type: COMPARATOR
Intervention: onabotulinumtoxinA
Number of subjects: 14
Study 23718573 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 0
Study 23718573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23718573 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (≥2 kg)
Number of subjects: 0
Study 23718573 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain (≥2 kg)
Number of subjects: 0
Study 21301358 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii at 2×10^6 live cells daily for 4 weeks
Number of subjects: 67
Study 21301358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 21301358 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii
Number of subjects: 67
Study 19587253 — intervention group
Group type: EXPERIMENTAL
Intervention: computer‐based virtual reality intervention
Number of subjects: 102
Study 19587253 — intervention group
Group type: COMPARATOR
Intervention: no training group
Number of subjects: 102
Study 17362174 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery with sevoflurane anesthesia
Number of subjects: 46
Study 17362174 — intervention group
Group type: COMPARATOR
Intervention: Laparotomic surgery with sevoflurane anesthesia
Number of subjects: 46
Study 14979482 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg once daily
Number of subjects: 34
Study 14979482 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin/tazobactam 4.5 g three times a day
Number of subjects: 34
Study 11430967 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding (solid food within 8 hours of surgery)
Number of subjects: 120
Study 11430967 — intervention group
Group type: COMPARATOR
Intervention: Control (nothing by mouth for 12-24 hours, then clear liquids, then solid food on the second or third postoperative day)
Number of subjects: 120
Study 9918416 — intervention group
Group type: EXPERIMENTAL
Intervention: tretinoin 0.1% (T)
Number of subjects: 30
Study 9918416 — intervention group
Group type: COMPARATOR
Intervention: tretinoin 0.1% with hydrocortisone 1% (C)
Number of subjects: 30
Study 9918416 — intervention group
Group type: COMPARATOR
Intervention: placebo cream (P)
Number of subjects: 30
Study 8063972 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 2
Study 8063972 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2
Study 2840013 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 25 mg/day
Number of subjects: 10
Study 2840013 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 50 mg/day
Number of subjects: 10
Study 2840013 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (in vitro, up to 10 micrograms/ml)
Number of subjects: 10
Study 2840013 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (in vitro, 0.1 microgram/ml)
Number of subjects: 10
Study 2840013 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31204604 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive intervention for family caregivers of patients with cancer
Number of subjects: 63
Study 31204604 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centered communication
Number of subjects: 63
Study 28281432 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified World Health Organization surgical safety checklist (MSSCL) implemented in maternity operating theatres
Number of subjects: 18
Study 28281432 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no MSSCL implementation)
Number of subjects: 18
Study 26790257 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved Nuti maneuver
Number of subjects: 40
Study 26790257 — intervention group
Group type: COMPARATOR
Intervention: Gufoni maneuver (Control)
Number of subjects: 40
Study 23739857 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) associated with full-mouth ultrasonic debridement
Number of subjects: 22
Study 23739857 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth ultrasonic debridement (Control)
Number of subjects: 22
Study 21900030 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based lifestyle counselling (Group A)
Number of subjects: 2738
Study 21900030 — intervention group
Group type: COMPARATOR
Intervention: Individual lifestyle counselling (Group B)
Number of subjects: 2738
Study 19573384 — intervention group
Group type: EXPERIMENTAL
Intervention: IST regimen I (cyclosporine A alone)
Number of subjects: 112
Study 19573384 — intervention group
Group type: EXPERIMENTAL
Intervention: IST regimen II (cyclosporine A and intravenous immunoglobulin)
Number of subjects: 112
Study 19573384 — intervention group
Group type: EXPERIMENTAL
Intervention: IST regimen III (rabbit anti-T-lymphocyte globulin and cyclosporine A)
Number of subjects: 112
Study 19573384 — intervention group
Group type: EXPERIMENTAL
Intervention: IST regimens I, II, and III
Number of subjects: 112
Study 16637377 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitocin (10 UI in 2 mL diluted in 18 mL saline solution)
Number of subjects: 64
Study 16637377 — intervention group
Group type: COMPARATOR
Intervention: Control (20 mL saline solution)
Number of subjects: 64
Study 15500695 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health First Aid training
Number of subjects: 753
Study 15500695 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 753
Study 11355937 — intervention group
Group type: EXPERIMENTAL
Intervention: ChlVPP/PABlOE
Number of subjects: 638
Study 11355937 — intervention group
Group type: COMPARATOR
Intervention: PABlOE
Number of subjects: 638
Study 9882081 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol after antacid (Maalox)
Number of subjects: 24
Study 9882081 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol after high-fat breakfast
Number of subjects: 24
Study 9882081 — intervention group
Group type: COMPARATOR
Intervention: Dexketoprofen trometamol in fasting condition
Number of subjects: 24
Study 8032167 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritanserin (2.5 mg, 5 mg, and 10 mg o.d.)
Number of subjects: 900
Study 8032167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study 2689036 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 7
Study 2689036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 4921703 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside and daunorubicin with L-asparaginase (N=10)
Number of subjects: 23
Study 4921703 — intervention group
Group type: COMPARATOR
Intervention: Cytosine arabinoside and daunorubicin without L-asparaginase (N=13)
Number of subjects: 23
Study 30944936 — intervention group
Group type: EXPERIMENTAL
Intervention: Ajust tape
Number of subjects: 100
Study 30944936 — intervention group
Group type: COMPARATOR
Intervention: TVT-O tape
Number of subjects: 100
Study 28840662 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-duration betrixaban
Number of subjects: 7513
Study 28840662 — intervention group
Group type: COMPARATOR
Intervention: Standard-duration enoxaparin
Number of subjects: 7513
Study 26646031 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids plus inositol
Number of subjects: 24
Study 22831953 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet only
Number of subjects: 276
Study 22831953 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity only
Number of subjects: 276
Study 22831953 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus physical activity
Number of subjects: 276
Study 22831953 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 276
Study 21467560 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL of 0.25% bupivacaine (TAP group)
Number of subjects: 40
Study 21467560 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 40
Study 19538204 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment of AED treatment (53 patients), either reduction of dose or switch of AED
Number of subjects: 111
Study 19538204 — intervention group
Group type: COMPARATOR
Intervention: Continuation of treatment unchanged (58 control patients)
Number of subjects: 111
Study 16776753 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine 0.2 mg twice daily for 16 weeks
Number of subjects: 0
Study 16776753 — intervention group
Group type: COMPARATOR
Intervention: Metformin 500 mg twice daily for 16 weeks
Number of subjects: 0
Study 16776753 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (Moxonidine and Metformin)
Number of subjects: 0
Study 15468561 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm of respiratory management (RM)
Number of subjects: 42
Study 15468561 — intervention group
Group type: COMPARATOR
Intervention: Routine RM algorithm (Control)
Number of subjects: 42
Study 15178175 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar patients
Number of subjects: 20
Study 15178175 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 15178175 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 10752919 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol powder 50 microg twice daily via Diskus
Number of subjects: 498
Study 10752919 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol aerosol 42 microg twice daily via MDI
Number of subjects: 498
Study 10752919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498
Study 8931532 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital testing of the bulbocavernous muscles, the sphincter ani externus, the puborectal muscles
Number of subjects: 39
Study 1532616 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 76
Study 1532616 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine plus metoprolol
Number of subjects: 76
Study 4029242 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prajmaline bitartrate
Number of subjects: 21
Study 4029242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 3144333 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 154
Study 3144333 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation and imagery training
Number of subjects: 154
Study 3144333 — intervention group
Group type: COMPARATOR
Intervention: Control group (talking about themselves)
Number of subjects: 154
Study 3144333 — intervention group
Group type: EXPERIMENTAL
Intervention: Women aged 55 and over
Number of subjects: 154
Study 3144333 — intervention group
Group type: EXPERIMENTAL
Intervention: Leeds general scales for depression and anxiety
Number of subjects: 154
Study 31712321 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Fat Overfeeding (HFOF) (60% fat, 20% carbohydrate)
Number of subjects: 79
Study 31712321 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Overfeeding (STOF) (50% carbohydrate, 30% fat)
Number of subjects: 79
Study 31712321 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Carbohydrate Overfeeding (HCOF) (75% carbohydrate, 5% fat)
Number of subjects: 79
Study 31712321 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting
Number of subjects: 79
Study 31712321 — intervention group
Group type: COMPARATOR
Intervention: Energy Balance (EBL) (50% carbohydrate, 30% fat)
Number of subjects: 79
Study 31415655 — intervention group
Group type: EXPERIMENTAL
Intervention: YH1
Number of subjects: 46
Study 31415655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 28843255 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention including information delivery, modeling, and persuasion through video presentation, group discussion, role playing, and postcards.
Number of subjects: 480
Study 28843255 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 480
Study 25967990 — intervention group
Group type: EXPERIMENTAL
Intervention: Holistic needs assessment (HNA) prior to consultation
Number of subjects: 0
Study 25967990 — intervention group
Group type: COMPARATOR
Intervention: Standard care - routine consultation between the patient and clinician
Number of subjects: 0
Study 23629717 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole (VCZ)
Number of subjects: 10
Study 23629717 — intervention group
Group type: EXPERIMENTAL
Intervention: N-oxide voriconazole (N-oxide VCZ)
Number of subjects: 10
Study 21737654 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection
Number of subjects: 285
Study 21737654 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 285
Study 21737654 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall costs of percutaneous ethanol injection
Number of subjects: 285
Study 21737654 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall costs of radiofrequency ablation
Number of subjects: 285
Study 19858981 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: Daily showering and brushing pin sites with soap and a soft toothbrush after initial 15 days of care (310 pin sites)
Number of subjects: 39
Study 19858981 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: Daily showering and cleaning crusts with sterile gauze impregnated with 10% polyvinylpyrrolidone iodine after initial 15 days of care (300 pin sites)
Number of subjects: 39
Study 16697307 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular (BV) pacing
Number of subjects: 30